[{"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1095000000.0,"CommonStockSharesConverted_0_FY_shares":1202000000.0,"Assets_0_FY_USD":50640000000.0,"RevenuesConverted_1_FY_USD":4454000000.0,"RevenuesConverted_4_FY_USD":16659000000.0,"NetIncomeLossConverted_1_FY_USD":162000000.0,"StockholdersEquity_0_FY_USD":10026000000.0,"EarningsPerShareDiluted_1_FY_USD":0.14,"EarningsPerShareDiluted_4_FY_USD":-3.64,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":1216000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1095000000.0,"StockholdersEquityConverted_0_FY_USD":11061000000.0,"NetIncomeLossConverted_4_FY_USD":-3990000000.0,"EarningsPerShareBasic_4_FY_USD":-3.64,"EarningsPerShareBasic_1_FY_USD":0.14,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210210"}]